Skip to main content

Supplementary Figure S1 from Single-Cell Transcriptomics Reveals Immune Landscape Dynamics in Metastatic Hormone Receptor–Positive Breast Cancer Treated with Abemaciclib and Endocrine Therapy

Other
Strawser, CH; Chakraborty, B; Michaud, D; Chang, C-Y; Dent, S; Jain, V; Tolaney, SM; Weinhold, K; McAllister, SS; Miller, KE; Steadman, K ...
August 3, 2026

<p>Supplementary Fig. S1. A) UMAP visualization of scRNA-seq data colored by patient identity. B) UMAP visualization of scRNA-seq data colored by timepoint (T1 = pre-abemaciclib and ET, T2 = post-abemaciclib and ET). C) Dot plot of proportion of copy number variation (CNV) in indicated chromosome per cluster. Size represents the percent of cells within each cluster in which a CNV was detected, and color represents the mean proportion of genes per cell with any CNV for the chromosome. D) Relative proportions of broad cell types per patient per timepoint per metastasis site.</p>

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

DOI

Publication Date

August 3, 2026
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Strawser, C. H., Chakraborty, B., Michaud, D., Chang, C.-Y., Dent, S., Jain, V., … Sammons, S. (2026). Supplementary Figure S1 from Single-Cell Transcriptomics Reveals Immune Landscape Dynamics in Metastatic Hormone Receptor–Positive Breast Cancer Treated with Abemaciclib and Endocrine Therapy. https://doi.org/10.1158/1078-0432.33143001
Strawser, Corinne H., Binita Chakraborty, Daniel Michaud, Ching-Yi Chang, Susan Dent, Vaibhav Jain, Sara M. Tolaney, et al. “Supplementary Figure S1 from Single-Cell Transcriptomics Reveals Immune Landscape Dynamics in Metastatic Hormone Receptor–Positive Breast Cancer Treated with Abemaciclib and Endocrine Therapy,” August 3, 2026. https://doi.org/10.1158/1078-0432.33143001.
Strawser CH, Chakraborty B, Michaud D, Chang C-Y, Dent S, Jain V, Tolaney SM, Weinhold K, McAllister SS, Miller KE, Steadman K, Arvai S, Hocke E, Agrawal Y, Perou CM, Goel S, McDonnell DP, Guerriero JL, Sammons S. Supplementary Figure S1 from Single-Cell Transcriptomics Reveals Immune Landscape Dynamics in Metastatic Hormone Receptor–Positive Breast Cancer Treated with Abemaciclib and Endocrine Therapy. 2026.

DOI

Publication Date

August 3, 2026